FILTER

Refine your search with the following facets to narrow down your results.

6 Current news of Innogenetics Group

Innogenetics achieves CE mark for new human papillomavirus (HPV) genotyping test

04-Jun-2008 - Innogenetics announced that it has received CE marking for its new and expanded HPV genotyping test, the INNO-LiPA HPV Genotyping Extra. The new generation kit allows the genotyping of 28 different HPV genotypes, of which 18 are high-risk types for the possible development of cervical cancer. The ...

cervical cancer genotyping HPV +1

Innogenetics concludes settlement and licensing agreement in the field of Hepatitis C diagnostics

19-Oct-2007 - Innogenetics announced an agreement with Novartis on major licensing terms in the field of Hepatitis C Virus (HCV) diagnostics. According to the license agreement, Novartis grants Innogenetics a license to its Hepatitis C patent rights in the field of HCV immunodiagnostics in certain territories. ...

Chiron diagnostics hepatitis C +5

Innogenetics signs exclusive agreement with AdnaGen to develop and commercialize new multiplex oncology tests

15-Oct-2007 - Innogenetics NV and AdnaGen AG announced that they have entered into an exclusive worldwide license agreement to develop and commercialize new multiplex tests in the field of oncology. The diagnostic tests rely on circulating tumour cells in patients' blood. The exclusive license covers fields ...

colon cancer diagnostic tests in-vitro diagnostics +2

Innogenetics presents research results for first Alzheimer biomarker test in blood

14-Jun-2007 - At the Alzheimer's Association's International Conference on Prevention of Dementia, Innogenetics presented research results with the first commercial blood test for beta-amyloid protein. Beta-amyloid is one of the potential biomarkers for Alzheimer's disease. With this new test, the INNO-BIA ...

Alzheimer's disease biomarker biomarkers +8

Innogenetics receives unanimous verdict against Abbott

05-Sep-2006 - On Friday, September 1, 2006, a Jury unanimously upheld the validity of Innogenetics' patent, U.S. Patent No. 5,846,704 ("the '704 patent"), which claims a method of genotyping the Hepatitis C Virus ("HCV"). The dispute began in September 2005 when Innogenetics brought suit against Abbott ...

Abbott genotyping hepatitis C +1

Innogenetics acquires full PCR license from Roche Diagnostics

20-Oct-2005 - Innogenetics and Roche Diagnostics announced that they have signed an agreement by which Roche has granted Innogenetics a full, worldwide license for the use of its patented polymerase chain reaction (PCR) technology in the development and commercialization of Innogenetics' molecular diagnostic ...

diagnostic tests PCR reagents +2